Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Palbociclib suppresses the cancer stem cell properties and cell proliferation through increased levels of miR-506 or miR-150 in Panc-1 and MiaPaCa-2 cells. | Turk J Biol | 2022 | 37529006 | PubTator, text mining | PubMed |
| Multi-color RNA imaging with CRISPR-Cas13b systems in living cells. | Cell Insight | 2022 | 37192858 | PubTator, text mining | PubMed |
| The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models. | Cancer Res Commun | 2022 | 36922934 | PubTator, text mining | PubMed |
| Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. | Front Mol Biosci | 2022 | 36866106 | PubTator, text mining | PubMed |
| Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis. | Cancer Res Commun | 2022 | 36860703 | PubTator, text mining | PubMed |
| Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing. | Front Immunol | 2022 | 36713456 | PubTator, text mining | PubMed |
| Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. | Front Cell Dev Biol | 2022 | 36712973 | PubTator, text mining | PubMed |
| Natural biomolecules and derivatives as anticancer immunomodulatory agents. | Front Immunol | 2022 | 36700235 | PubTator, text mining | PubMed |
| Advances in research on the relationship between thymoquinone and pancreatic cancer. | Front Oncol | 2022 | 36686732 | PubTator, text mining | PubMed |
| SADLN: Self-attention based deep learning network of integrating multi-omics data for cancer subtype recognition. | Front Genet | 2022 | 36685873 | PubTator, text mining | PubMed |
| Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. | World J Gastroenterol | 2022 | 36632312 | PubTator, text mining | PubMed |
| Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. | Front Cell Dev Biol | 2022 | 36619866 | PubTator, text mining | PubMed |
Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM). | Front Immunol | 2022 | 36618415 | PubTator, text mining | PubMed |
| Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. | Nutrients | 2022 | 36615808 | PubTator, text mining | PubMed |
| Cell-Free Supernatant from Lactobacillus and Streptococcus Strains Modulate Mucus Production via Nf-κB/CREB Pathway in Diesel Particle Matter-Stimulated NCI-H292 Airway Epithelial Cells. | Molecules | 2022 | 36615255 | PubTator, text mining | PubMed |
| Extracellular Vesicles' Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD. | Int J Mol Sci | 2022 | 36613669 | PubTator, text mining | PubMed |
| Isthmin-A Multifaceted Protein Family. | Cells | 2022 | 36611811 | PubTator, text mining | PubMed |
| EWSR1::SMAD3-rearranged fibroblastic tumor: A case with twice recurrence and literature review. | Front Oncol | 2022 | 36591513 | PubTator, text mining | PubMed |
| Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma. | Front Immunol | 2022 | 36582227 | PubTator, text mining | PubMed |
| Mystery Behind Barrett's Esophagus: The Origin and Malignant Transformation of Esophageal Adenocarcinoma. | Glob Med Genet | 2022 | 36567952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=38